DrugLib.com — Drug Information Portal

Rx drug information, pharmaceutical research, clinical trials, news, and more

Depo-Subq Provera (Medroxyprogesterone Acetate Subcutaneous) - Published Studies

 


Nutrilib.com
A comprihensive source of nutritional information

Published Studies Related to Depo-Subq Provera (Medroxyprogesterone Subcutaneous)

Well-designed clinical trials related to Depo-Subq Provera (Medroxyprogesterone Subcutaneous)

Estrogen, medroxyprogesterone acetate, endothelial function, and biomarkers of cardiovascular risk in young women. [2008.04]

Medroxyprogesterone, interferon alfa-2a, interleukin 2, or combination of both cytokines in patients with metastatic renal carcinoma of intermediate prognosis: results of a randomized controlled trial. [2007.12.01]

Medroxyprogesterone, interferon alfa-2a, interleukin 2, or combination of both cytokines in patients with metastatic renal carcinoma of intermediate prognosis : results of a randomized controlled trial. [2007.10.11]

Testosterone gel combined with depomedroxyprogesterone acetate is an effective male hormonal contraceptive regimen and is not enhanced by the addition of a GnRH antagonist. [2006.11]

Changes in bleeding patterns with depot medroxyprogesterone acetate subcutaneous injection 104 mg. [2006.09]

Subcutaneous injection of depot medroxyprogesterone acetate compared with leuprolide acetate in the treatment of endometriosis-associated pain. [2006.02]

Subcutaneous depot medroxyprogesterone acetate versus leuprolide acetate in the treatment of endometriosis-associated pain. [2006.01]

Other research related to Depo-Subq Provera (Medroxyprogesterone Subcutaneous)

EFFECTS IN POSTMENOPAUSAL WOMEN OF ESTRADIOL AND MEDROXYPROGESTERONE ALONE AND COMBINED ON RESISTANCE ARTERY FUNCTION AND ENDOTHELIAL MORPHOLOGY AND MOVEMENT. [2008.03.04]

Addition of medroxyprogesterone acetate to conjugated equine estrogens results in insulin resistance in adipose tissue. [2007.06]

Changes in weight with depot medroxyprogesterone acetate subcutaneous injection 104 mg/0.65 mL. [2007.04]

Acceptability of a combination testosterone gel and depomedroxyprogesterone acetate male contraceptive regimen. [2007.03]

The acceptability of self-administration of subcutaneous Depo-Provera. [2005.07]

Other possibly related research studies

The role of progestins in treating the pain of endometriosis. [2006.11]

Advances in hormonal contraception. [2006.10]

Advances in the management of endometriosis: an update for clinicians. [2006.03]

Morphometric evaluation of effects of two sex steroids on mammary gland of female rats. [2005.08.16]

Subcutaneous administration of pulsatile gonadotropin-releasing hormone decreases serum follicle-stimulating hormone and luteinizing hormone levels in women with polycystic ovary syndrome: a preliminary study. [2005.05]

Effects of postmenopausal hormone replacement therapy on body fat composition. [2007.02]

Does injection of prostaglandin F(2alpha) (PGF2alpha) cause ovulation in anestrous Western White Face ewes? [2006.07.15]

Efficacy of levamisole on experimental endometriosis. [2007.10]

Self-administration of injectable contraceptives. [2008.05]

-- advertisement -- The American Red Cross

We comply with
HONcode standard.
Verify here.
Home | About Us | Contact Us | Site usage policy | Privacy policy

All Rights reserved - Copyright DrugLib.com, 2006-2008